CA1171860A - Oxazolidinedione derivatives - Google Patents
Oxazolidinedione derivativesInfo
- Publication number
- CA1171860A CA1171860A CA000413239A CA413239A CA1171860A CA 1171860 A CA1171860 A CA 1171860A CA 000413239 A CA000413239 A CA 000413239A CA 413239 A CA413239 A CA 413239A CA 1171860 A CA1171860 A CA 1171860A
- Authority
- CA
- Canada
- Prior art keywords
- hydrogen
- spiro
- trione
- oxazolidine
- indoline
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D498/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
- C07D498/10—Spiro-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
- C07D209/04—Indoles; Hydrogenated indoles
- C07D209/30—Indoles; Hydrogenated indoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to carbon atoms of the hetero ring
- C07D209/32—Oxygen atoms
- C07D209/38—Oxygen atoms in positions 2 and 3, e.g. isatin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Diabetes (AREA)
- Medicinal Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Endocrinology (AREA)
- Emergency Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Indole Compounds (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US31068281A | 1981-10-13 | 1981-10-13 | |
| US310,682 | 1981-10-13 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CA1171860A true CA1171860A (en) | 1984-07-31 |
Family
ID=23203647
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CA000413239A Expired CA1171860A (en) | 1981-10-13 | 1982-10-12 | Oxazolidinedione derivatives |
Country Status (16)
| Country | Link |
|---|---|
| EP (1) | EP0079675A1 (enExample) |
| JP (1) | JPS5877883A (enExample) |
| KR (1) | KR860000486B1 (enExample) |
| AR (1) | AR231839A1 (enExample) |
| AU (1) | AU531161B2 (enExample) |
| CA (1) | CA1171860A (enExample) |
| DK (1) | DK449882A (enExample) |
| ES (1) | ES515751A0 (enExample) |
| FI (1) | FI823480L (enExample) |
| GR (1) | GR77019B (enExample) |
| HU (1) | HU185113B (enExample) |
| IL (1) | IL66954A (enExample) |
| PH (1) | PH18038A (enExample) |
| PL (1) | PL238595A1 (enExample) |
| PT (1) | PT75673B (enExample) |
| YU (1) | YU229382A (enExample) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ZA832679B (en) * | 1982-05-07 | 1983-12-28 | Ici Plc | Indoline derivatives |
| DE3561198D1 (en) * | 1984-03-23 | 1988-01-28 | Pfizer | Spiro-indenes and spiro-1,2-dihydro-naphthalenes for treatment of diabetic complications |
| HU203330B (en) * | 1987-06-10 | 1991-07-29 | Pfizer | Process for producing oxazolidin-2-one derivatives and hypoglychemic pharmaceutical compositions containing them |
| AU617541B2 (en) * | 1988-10-20 | 1991-11-28 | Wyeth | Spiro-isoquinoline-pyrrolidine tetrones and analogs thereof useful as aldose reductase inhibitors |
| US5221686A (en) * | 1992-08-04 | 1993-06-22 | American Home Products Corporation | Spiro[1,2-benzisothiazole-3(2H),5'-oxazolidine]-2',4'-dione 1,1-dioxides as antihyperglycemic agents |
| FR2708606B1 (fr) * | 1993-07-30 | 1995-10-27 | Sanofi Sa | Dérivés du N-phénylalkylindol-2-one, leur préparation, les compositions pharmaceutiques en contenant. |
| CN102336769A (zh) * | 2011-07-06 | 2012-02-01 | 华东理工大学 | 一种简便的合成螺[氧化吲哚-3,5＇-噁唑啉]杂环化合物的新方法 |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4200642A (en) * | 1978-08-21 | 1980-04-29 | Pfizer Inc. | Spiro-oxazolidindiones |
-
1982
- 1982-09-16 ES ES515751A patent/ES515751A0/es active Granted
- 1982-10-08 EP EP82305385A patent/EP0079675A1/en not_active Withdrawn
- 1982-10-11 IL IL66954A patent/IL66954A/xx unknown
- 1982-10-11 KR KR8204569A patent/KR860000486B1/ko not_active Expired
- 1982-10-11 YU YU02293/82A patent/YU229382A/xx unknown
- 1982-10-11 AR AR290934A patent/AR231839A1/es active
- 1982-10-11 GR GR69495A patent/GR77019B/el unknown
- 1982-10-12 PH PH27974A patent/PH18038A/en unknown
- 1982-10-12 DK DK449882A patent/DK449882A/da not_active Application Discontinuation
- 1982-10-12 PT PT75673A patent/PT75673B/pt unknown
- 1982-10-12 HU HU823246A patent/HU185113B/hu unknown
- 1982-10-12 PL PL23859582A patent/PL238595A1/xx unknown
- 1982-10-12 AU AU89288/82A patent/AU531161B2/en not_active Ceased
- 1982-10-12 FI FI823480A patent/FI823480L/fi not_active Application Discontinuation
- 1982-10-12 CA CA000413239A patent/CA1171860A/en not_active Expired
- 1982-10-13 JP JP57179684A patent/JPS5877883A/ja active Granted
Also Published As
| Publication number | Publication date |
|---|---|
| KR860000486B1 (ko) | 1986-04-30 |
| ES8400116A1 (es) | 1983-10-16 |
| PH18038A (en) | 1985-03-08 |
| JPS611073B2 (enExample) | 1986-01-13 |
| AU8928882A (en) | 1983-04-21 |
| AU531161B2 (en) | 1983-08-11 |
| PL238595A1 (en) | 1983-09-12 |
| PT75673A (en) | 1982-11-01 |
| PT75673B (en) | 1985-12-09 |
| DK449882A (da) | 1983-04-14 |
| IL66954A (en) | 1985-02-28 |
| HU185113B (en) | 1984-12-28 |
| ES515751A0 (es) | 1983-10-16 |
| FI823480A7 (fi) | 1983-04-14 |
| FI823480A0 (fi) | 1982-10-12 |
| EP0079675A1 (en) | 1983-05-25 |
| KR840002002A (ko) | 1984-06-11 |
| JPS5877883A (ja) | 1983-05-11 |
| GR77019B (enExample) | 1984-09-04 |
| FI823480L (fi) | 1983-04-14 |
| IL66954A0 (en) | 1983-02-23 |
| AR231839A1 (es) | 1985-03-29 |
| YU229382A (en) | 1984-12-31 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP4229701B2 (ja) | β−ラクタム化合物及びその製造方法並びにこれを含有する血清コレステロール低下剤 | |
| SU942597A3 (ru) | Способ получени спирооксазолидиндионов | |
| GB1572688A (en) | Spirohydantoins | |
| EP0252713A1 (en) | Indolinone derivatives | |
| US4738972A (en) | Hypoglycemic thiazolidinediones | |
| CA1171860A (en) | Oxazolidinedione derivatives | |
| US4587256A (en) | Novel thiazolidine derivatives | |
| JPH0825877B2 (ja) | 眼科治療用組成物 | |
| US4940708A (en) | 4-arylsulfonyl-3,4-dihydro-2(1H)-quinoxalinone-1-alkanoic acids, esters, and salts | |
| US4464380A (en) | Imidazolidinedione derivatives | |
| EP0019440B1 (en) | Benzimidazolone derivatives, process for their preparation and pharmaceutical compositions containing them | |
| EP0269355B1 (en) | Imidazolidinedione derivatives | |
| KR860001581B1 (ko) | 스피로-3-헤테로-아졸론의 제조방법 | |
| US4533667A (en) | Imidazolidinedione derivatives | |
| CA1226866A (en) | Hydantoin derivatives | |
| FI80682C (fi) | Foerfarande foer framstaellning av aldosreduktas inhibears 5-(2-alkoxi-3-substituerad fenyl)hydantoiner. | |
| HU200603B (en) | Process for producing substituted quinoxalinyl-imidazolidin-2,4-diones and pharmaceutical compositions comprising such compounds | |
| JPS59206384A (ja) | 新規１′−（４−ブロム−２−フルオルベンジル）−７′−クロル−スピロ〔イミダゾリジン−４，３−インドリン〕−２，２′，５−トリオン、その製造法及び前記化合物を含有し糖尿病合 | |
| JPH07133274A (ja) | ピロール誘導体 | |
| EP0117035A2 (en) | Aldose reductase inhibiting 5-(2-alkoxyphenyl)thiazolidinediones | |
| JPH0583554B2 (enExample) | ||
| KR860001870B1 (ko) | 이미다졸리딘디온 유도체의 제조방법 | |
| KR830000329B1 (ko) | 스피로-옥사졸리딘디온의 제조방법 | |
| Villani et al. | Derivatives of 2-azabicyclo [2.2. 2] octane. III. Substituted phenylsulfonylureido derivatives | |
| NZ194846A (en) | Hydrobenzopyrans (or furans)or thio functions and their preparations |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| MKEC | Expiry (correction) | ||
| MKEX | Expiry |